Regulations/Legal

Latest Issue of OR Manager
May 2025
Home Regulations/Legal

Occurrence, transmission of asymptomatic vs symptomatic COVID-19 infections

Editor's Note Based on this update of a systematic review and meta-analysis of 130 studies, led by researchers from the University of Bern, Switzerland, most COVID-19 infections were not persistently asymptomatic, and asymptomatic infections were less infectious than symptomatic infections. Because of variability among studies, the meta-analysis did not calculate…

Read More

By: Judy Mathias
May 31, 2022
Share

US COVID-19 cases to rise through June

Editor's Note Modeling suggests that COVID-19 cases, hospitalizations, and deaths will rise through at least mid-June, as the Omicron subvariants BA.2 and BA.2.12.1 spread through the US, the May 31 Becker’s Hospital Review reports. Three COVID-19 forecasts to watch, include: Cases. Daily cases are projected to increase more than 84%…

Read More

By: Judy Mathias
May 31, 2022
Share

FDA: Class I recall of Abbott’s Dragonfly OpStar Imaging Catheter

Editor's Note The Food and Drug Administration (FDA) on May 26 identified the recall of Abbott Medical’s Dragonfly OpStar Imaging Catheter as Class I, the most serious. Abbott is recalling certain lots of the imaging catheter because the marker band farthest from the catheter tip (proximal marker) may become loose…

Read More

By: Judy Mathias
May 31, 2022
Share

UW Medicine conducting national clinical trial on inflatable tubular stent

Editor's Note Cardiologists at the University of Washington School of Medicine (UW Medicine) in Seattle, Washington, are participating in a national clinical trial to test a device designed to control bleeding if a vessel near the heart is inadvertently perforated during a catheter-based procedure, Healthcare Purchasing News May 26 reported.…

Read More

By: Tarsilla Moura
May 26, 2022
Share

Sponsored Message

ECRI: 2022 winners of Alerts Impact Award

Editor's Note ECRI on May 25 announced the three winners and three finalists of its 2022 Alerts Impact Award for excellence in recall management. The annual award is given to those who have demonstrated strong success in implementing recall management programs in their healthcare organizations. The winners are: Eskenazi Health,…

Read More

By: Judy Mathias
May 26, 2022
Share

The Joint Commission: Accelerate PI Dashboard Reports available

Editor's Note The Joint Commission on May 25 announced that refreshed Accelerate PI Dashboard Reports are available for accredited hospitals and critical access hospitals to provide updated performance measurement data on a select subset of quality measures. The Interim ORYX reports contain data through the second quarter of 2021, and…

Read More

By: Judy Mathias
May 26, 2022
Share

Sponsored Message

Georgia becomes eighth state to go smoke-free

Editor's Note On May 9, Governor Brian Kemp of Georgia signed into law SB573, which requires the evacuation of smoke during plume-producing surgical procedures. The law states: “Each hospital and ambulatory surgical center shall adopt policies for the reduction of human exposure to surgical smoke.” Brenda Ulmer, MN, RN, CNOR,…

Read More

By: Judy Mathias
May 25, 2022
Share

Surgeon General Advisory highlights need to address HCW burnout

Editor's Note Surgeon General Vivek Murthy, MD, on May 23, issued an Advisory highlighting the impact of the COVID-19 pandemic on healthcare workers (HCWs) and the urgent need to address HCW burnout across the country. Among the Advisory’s recommendations: Transforming workplace cultures to empower HCWs and be responsive to their…

Read More

By: Judy Mathias
May 25, 2022
Share

CDC health advisory update on treating COVID-19 recurrence with antiviral pill

Editor's Note The Centers for Disease Control and Prevention (CDC) on May 24 issued a Health Alert Network Health Advisory to update healthcare providers and the public on treating the potential for recurrence of COVID-19, also termed “COVID-19 rebound.” According to the health advisory update, there is “currently no evidence…

Read More

By: Tarsilla Moura
May 25, 2022
Share

FDA: Class I recall of Woodside Acquisitions SARS-CoV-2 antigen rapid test kits

Editor's Note The Food and Drug Administration (FDA) on May 16 identified the recall of Woodside Acquisitions Inc’s Oral Rapid SARS-CoV-2 Antigen Rapid Test Kits and Joysbio SARS-CoV-2 Antigen Rapid Test Kits (Colloidal Gold) as Class I, the most serious. The tests are being recalled because they were distributed to…

Read More

By: Judy Mathias
May 24, 2022
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat